Analysis | Sample size | Outcome measure | ∆C (95% CI) | ∆E (95% CI) | ICER | Distribution CE-plane (%) | ||||
---|---|---|---|---|---|---|---|---|---|---|
 | Control | Intervention |  | € | Points | €/point | NE | SE | SW | NW |
Main analysis - Imputed dataset | 128 | 118 | QALYs (Range: 0–1) | 131 (− 3039 to 3928) | − 0.008 (− 0.04 to 0.03) | −16,198 | 17.4 | 14.4 | 32.1 | 36.0 |
128 | 118 | OMAS (Range: 0–100) | 131 (− 3039 to 3928) | 0.73 (− 5.29 to 6.76) | 178 | 21.4 | 31.8 | 15.0 | 25.8 | |
SA1 – Complete cases | 29 | 23 | QALYs (Range: 0–1) | 1242 (− 7949 to 6447) | −0.014 (− 0.06 to 0.04) | −86,988 | 46.0 | 7.5 | 10.9 | 35.6 |
 | 29 | 23 | OMAS (Range: 0–100) | 1242 (−7949 to 6447) | 3.04 (− 5.82 to 11.89) | 409 | 70.1 | 16.2 | 2.8 | 10.8 |
SA2 – QALY 1 VS QALY 2 | 128 | 118 | QALYs (Range: 0–1) | 131 (−3039 to 3947) | −0.013 (− 0.05 to 0.02) | − 10,394 | 8.3 | 15.9 | 30.8 | 45.0 |
SA3 – Human capital approach | 128 | 118 | QALYs (Range: 0–1) | 383 (− 2900 to 4365) | −0.008 (− 0.04 to 0.03) | −47,311 | 19.2 | 13.2 | 29.8 | 39.9 |
 | 128 | 118 | OMAS (Range: 0–100) | 383 (− 2900 to 4365) | 0.73 (− 5.29 to 6.75) | 527 | 30.6 | 28.9 | 13.2 | 27.4 |
SA4 – Healthcare perspective | 128 | 118 | QALYs (Range: 0–1) | − 89 (− 2386 to 3287) | −0.008 (− 0.04 to 0.03) | 11,052 | 14.3 | 17.2 | 36.4 | 32.1 |
 | 128 | 118 | OMAS (Range: 0–100) | −89 (−2386 to 3287) | 0.73 (−5.29 to 6.75) | −121 | 23.6 | 36.2 | 17.4 | 22.8 |
SA5 – Conservative treatment | 51 | 41 | QALYs (Range: 0–1) | − 2425 (− 9691 to 1223) | −0.03 (− 0.09 to 0.02) | 74,883 | 3.7 | 8.1 | 66.2 | 22.0 |
51 | 41 | OMAS (Range: 0–100) | −2425 (− 9691 to 1223) | − 1.60 (−10.49 to 7.30) | 1519 | 6.2 | 28.5 | 45.5 | 19.8 | |
SA6 – Operative treatment | 77 | 77 | QALYs (Range: 0–1) | 1432 (− 3007 to 6706) | 0.001 (−0.04 to 0.04) | 1,504,404 | 39.0 | 15.5 | 14.7 | 30.9 |
 | 77 | 77 | OMAS (Range: 0–100) | 1432 (−3007 to 6706) | 1.51 (−5.07 to 8.08) | 951 | 50.6 | 24.7 | 4.3 | 20.4 |